Total Voting Rights

RNS Number : 0222W
Fair Oaks Income Limited
31 July 2018
 

Fair Oaks Income Limited

31 July 2018

FAIR OAKS INCOME LIMITED (the "Company")

 

(Incorporated in Guernsey under The Companies (Guernsey) Law, 2008, as amended, with registered number 58123 and registered as a Registered Closed-ended Collective Investment Scheme with the Guernsey Financial Services Commission)

 

                                       

Confirmation of Voting Rights

 

The Directors of the Company wish to announce that the total number of voting rights in respect of the following classes of shares are:

Share Class

Number of shares in issue

Total Number of Voting Rights in Share Class

2017 Shares

2014 Shares

453,348,737

39,335,595

         453,348,737

         39,335,595

Aggregate                                                              492,684,332                                        492,684,332*

The Company holds no shares in Treasury.

* Under the Articles, at any general meeting of the Company each Share (2014 Share and 2017 Share) shall have one vote. Accordingly, the figure which may be used by the Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules is the aggregate of Shares, namely 492,684,332. Similarly, to calculate the numerator, Shareholders should aggregate their holdings of 2014 Shares and 2017 Shares to calculate the relevant number of voting rights for the numerator.

 

LEI: 2138008KETEC1WM5YP90

 

Enquiries:

 

Praxis Fund Services Limited

Shona Darling

DDI: +44 (0) 1481 755528

Email: shona.darling@praxisgroup.com

 

 

Numis Securities Limited

Nathan Brown, Corporate Broking

DDI: +44 (0) 20 7260 1426

Email: n.brown@numis.com

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVREAEXXAELPEFF
UK 100